Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1596981

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1596981

Antipyretic Drugs For Children Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Antipyretic drugs for children are medications specifically designed to reduce fever. They function by lowering the body's temperature through various mechanisms, including the inhibition of fever-inducing substances. These drugs help alleviate discomfort and prevent complications related to high fever in children.

The primary classes of antipyretic drugs for children include acetaminophen, ibuprofen, and others. Acetaminophen, also known as paracetamol, is an analgesic and antipyretic medication that provides pain relief and reduces fever without having anti-inflammatory properties. Available dosage forms include tablets, syrups, suppositories, and others, tailored for different age groups, such as newborns, infants, toddlers, and children.

The antipyretic drugs for children market research report is one of a series of new reports from The Business Research Company that provides antipyretic drugs for children market statistics, including antipyretic drugs for children industry global market size, regional shares, competitors with a antipyretic drugs for children market share, detailed antipyretic drugs for children market segments, market trends and opportunities, and any further data you may need to thrive in the antipyretic drugs for children industry. This antipyretic drugs for children market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antipyretic drugs for children market size has grown strongly in recent years. It will grow from $3.02 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historic period can be attributed to several factors, including heightened awareness of pediatric health, which has led to increased demand for antipyretic medications. Additionally, there has been a growing incidence of fever-related illnesses in children globally, along with rising healthcare expenditures among families for treating common childhood fevers. Access to over-the-counter antipyretic drugs has also improved in emerging markets, and there is an increasing emphasis on preventive healthcare and early intervention for pediatric fevers.

The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth during the forecast period can be attributed to a rising focus on advancements in pediatric healthcare, which is increasing the demand for safer antipyretic drugs. Additionally, the growing prevalence of viral infections in children is fueling the need for antipyretic treatments. There are also increasing government initiatives aimed at improving access to pediatric healthcare in developing countries, along with advances in drug formulations and delivery mechanisms that enhance the efficacy of antipyretics. Furthermore, the expansion of pharmaceutical companies in emerging markets is driving the availability of pediatric medications. Key trends expected during this period include technological innovations in pediatric drug formulations for faster and safer fever relief, a shift towards natural and herbal-based antipyretic drugs for children, an increasing emphasis on personalized treatments for managing fevers, a growing adoption of telemedicine platforms for accessing pediatric consultations related to fever management, and the development of combination antipyretic drugs that target multiple symptoms in children.

The increasing prevalence of viral and bacterial infections is expected to drive growth in the antipyretic drugs market for children in the future. Viral infections occur when viruses invade and replicate within host cells, leading to diseases such as influenza (flu). Bacterial infections arise from harmful bacteria entering the body and multiplying, causing illnesses such as strep throat or tuberculosis. The rise in these infections can be attributed to factors such as growing antibiotic resistance, global travel, and increased population density, which facilitate the spread of pathogens. Antipyretic drugs, including acetaminophen and ibuprofen, are commonly used in children to reduce fever and alleviate discomfort associated with these infections. For example, the Office for National Statistics, a UK-based non-ministerial department, reported that between December 2021 and March 2022, there were 6,898 deaths due to flu and pneumonia in the UK, up from 5,288 deaths in the same period of 2020-2021. This represents an increase of over 1,600 deaths year-over-year. Consequently, the rising incidence of viral and bacterial infections is fueling the growth of the antipyretic drugs market for children.

The increasing birth rates are expected to contribute to the growth of the antipyretic drug market for children. The birth rate refers to the number of live births per 1,000 people in a population each year. This increase can be attributed to better access to healthcare, improved economic conditions, and higher fertility rates in certain regions. A higher birth rate leads to greater demand for antipyretic drugs for children, as a larger population of infants and young children necessitates more medical care, including fever management. For instance, the Registry of Births, Deaths, and Marriages in Victoria, an electronic resource based in Australia, reported that the number of births registered in Victoria rose from 7,689 in July 2024 to 7,994 in August 2024. Therefore, the growing birth rates are driving the antipyretic drug market for children.

Key players in the antipyretic drugs market for children are concentrating on developing advanced drug formulations, such as medicine gummy bites, to improve ease of administration and enhance compliance among young patients. Medicine gummy bites are chewable, gummy medications designed to make taking medicine more appealing, especially for children. They come in various forms and flavors to encourage compliance and simplify the process. For example, in October 2023, DrKids, a US-based pharmaceutical company, launched an acetaminophen gummy bite. This innovative medication provides a child-friendly alternative for pain and fever relief and features an exact dosing system that simplifies medicine administration for parents while ensuring safety and effectiveness.

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited

North America was the largest region in the antipyretic drugs for children market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antipyretic drugs for children market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antipyretic drugs for children market consists of sales of acetaminophen (tylenol), ibuprofen (advil, motrin), and naproxen (aleve). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antipyretic Drugs For Children Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antipyretic drugs for children market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antipyretic drugs for children ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antipyretic drugs for children market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Class: Acetaminophen; Ibuprofen; Other Drug Classes
  • 2) By Dosage Form: Tablets; Syrups; Suppositories; Other Dosage Forms
  • 3) By Age Group: Newborns; Infants; Toddlers; Children
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r20130

Table of Contents

1. Executive Summary

2. Antipyretic Drugs For Children Market Characteristics

3. Antipyretic Drugs For Children Market Trends And Strategies

4. Antipyretic Drugs For Children Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Antipyretic Drugs For Children Market Size and Growth

  • 5.1. Global Antipyretic Drugs For Children Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Antipyretic Drugs For Children Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Antipyretic Drugs For Children Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antipyretic Drugs For Children Market Segmentation

  • 6.1. Global Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acetaminophen
  • Ibuprofen
  • Other Drug Classes
  • 6.2. Global Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tablets
  • Syrups
  • Suppositories
  • Other Dosage Forms
  • 6.3. Global Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Newborns
  • Infants
  • Toddlers
  • Children

7. Antipyretic Drugs For Children Market Regional And Country Analysis

  • 7.1. Global Antipyretic Drugs For Children Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Antipyretic Drugs For Children Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antipyretic Drugs For Children Market

  • 8.1. Asia-Pacific Antipyretic Drugs For Children Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antipyretic Drugs For Children Market

  • 9.1. China Antipyretic Drugs For Children Market Overview
  • 9.2. China Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antipyretic Drugs For Children Market

  • 10.1. India Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antipyretic Drugs For Children Market

  • 11.1. Japan Antipyretic Drugs For Children Market Overview
  • 11.2. Japan Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antipyretic Drugs For Children Market

  • 12.1. Australia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antipyretic Drugs For Children Market

  • 13.1. Indonesia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antipyretic Drugs For Children Market

  • 14.1. South Korea Antipyretic Drugs For Children Market Overview
  • 14.2. South Korea Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antipyretic Drugs For Children Market

  • 15.1. Western Europe Antipyretic Drugs For Children Market Overview
  • 15.2. Western Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antipyretic Drugs For Children Market

  • 16.1. UK Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antipyretic Drugs For Children Market

  • 17.1. Germany Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antipyretic Drugs For Children Market

  • 18.1. France Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antipyretic Drugs For Children Market

  • 19.1. Italy Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antipyretic Drugs For Children Market

  • 20.1. Spain Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antipyretic Drugs For Children Market

  • 21.1. Eastern Europe Antipyretic Drugs For Children Market Overview
  • 21.2. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antipyretic Drugs For Children Market

  • 22.1. Russia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antipyretic Drugs For Children Market

  • 23.1. North America Antipyretic Drugs For Children Market Overview
  • 23.2. North America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antipyretic Drugs For Children Market

  • 24.1. USA Antipyretic Drugs For Children Market Overview
  • 24.2. USA Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antipyretic Drugs For Children Market

  • 25.1. Canada Antipyretic Drugs For Children Market Overview
  • 25.2. Canada Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antipyretic Drugs For Children Market

  • 26.1. South America Antipyretic Drugs For Children Market Overview
  • 26.2. South America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antipyretic Drugs For Children Market

  • 27.1. Brazil Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antipyretic Drugs For Children Market

  • 28.1. Middle East Antipyretic Drugs For Children Market Overview
  • 28.2. Middle East Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antipyretic Drugs For Children Market

  • 29.1. Africa Antipyretic Drugs For Children Market Overview
  • 29.2. Africa Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antipyretic Drugs For Children Market Competitive Landscape And Company Profiles

  • 30.1. Antipyretic Drugs For Children Market Competitive Landscape
  • 30.2. Antipyretic Drugs For Children Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Antipyretic Drugs For Children Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol Myers Squibb
  • 31.3. GlaxoSmithKline plc
  • 31.4. Reckitt Benckiser Group
  • 31.5. Viatris Inc.
  • 31.6. Teva Pharmaceutical Industries Ltd.
  • 31.7. Sun Pharmaceutical Industries Ltd.
  • 31.8. Perrigo Company plc
  • 31.9. Aurobindo Pharma Ltd.
  • 31.10. Dr. Reddy's Laboratories Ltd.
  • 31.11. Cipla Ltd.
  • 31.12. Lupin Limited
  • 31.13. Towa Pharmaceutical Co Ltd
  • 31.14. Glenmark Pharmaceuticals Ltd.
  • 31.15. Alkem Laboratories Limited

32. Global Antipyretic Drugs For Children Market Competitive Benchmarking

33. Global Antipyretic Drugs For Children Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antipyretic Drugs For Children Market

35. Antipyretic Drugs For Children Market Future Outlook and Potential Analysis

  • 35.1 Antipyretic Drugs For Children Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Antipyretic Drugs For Children Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Antipyretic Drugs For Children Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!